Track Your Tirzepatide Protocol with Lifewheel

Yes. Lifewheel is a dedicated iOS app for tracking Mounjaro (tirzepatide) protocols. It supports weekly scheduling, dose escalation tracking from 2.5 mg through 15 mg, application site rotation, and metabolic biomarker correlation including weight and A1C. Unlike generic medication reminders, Lifewheel is designed specifically for compound protocols and understands the full tirzepatide escalation schedule.

Lifewheel tracks your tirzepatide dose schedule automatically. When you set up a tirzepatide protocol in the app, it maps the standard escalation from 2.5 mg to 15 mg across four-week intervals. You receive weekly reminders on your chosen day, log each application with a single tap, and can see your current dose level and next escalation date at a glance on the dashboard. If your provider adjusts the timeline, you can customize escalation intervals within the app.

Yes. Lifewheel fully supports Zepbound (tirzepatide for chronic weight management). The app tracks your weekly applications, monitors dose escalation through all six dose levels, logs weight trends over time, and correlates your progress with metabolic lab results including A1C, fasting glucose, and lipid panels. Zepbound and Mounjaro use the same active ingredient (tirzepatide) and the same escalation schedule, so Lifewheel handles both identically.

Lifewheel is the most comprehensive tirzepatide tracker app available for iOS. It goes beyond simple medication reminders by offering compound-specific dose escalation tracking, application site rotation management, side effect logging, and metabolic biomarker correlation. The app understands tirzepatide's six-step escalation schedule, visualizes your progress over time, and lets you export your complete protocol history as a CSV for your healthcare provider.

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin hormone receptors simultaneously. Semaglutide targets only the GLP-1 receptor. In head-to-head clinical comparisons (SURPASS and SURMOUNT trials), tirzepatide demonstrated greater weight reduction and glycemic control. Tirzepatide achieved up to 22.5% weight loss in clinical trials, compared to semaglutide's 16.9%. Both are administered once weekly via subcutaneous application. Lifewheel tracks both compounds with full escalation support.

Yes. Lifewheel lets you log lab results including A1C, fasting glucose, lipid panels (total cholesterol, LDL, HDL, triglycerides), liver enzymes (ALT, AST), and other metabolic markers. The app correlates your tirzepatide protocol timeline with your lab trends, so you can visualize how your biomarkers respond at each dose level. This is particularly valuable for tracking A1C improvements over the escalation period and sharing data with your endocrinologist.

Yes. Lifewheel sends configurable weekly reminders for your tirzepatide application. You choose the day of the week and time of day, and the app delivers a push notification when it is time to administer. The app also tracks whether you have logged your weekly application and flags overdue doses. Because tirzepatide is a once-weekly medication, staying on schedule is critical for consistent results, and Lifewheel makes it effortless.

Yes. Lifewheel supports CSV export of your complete Mounjaro (tirzepatide) protocol history. The export file includes application dates and times, the amount administered at each application, the application site used, any side effects logged, and correlated biomarker data such as weight and A1C readings. You can share this file via email, AirDrop, or any iOS share method directly from the app. Many users bring this export to their quarterly endocrinology appointments for a complete picture of their protocol adherence.

Yes. Lifewheel supports tracking multiple compounds simultaneously in a unified dashboard. You can manage your tirzepatide protocol alongside other peptides (BPC-157, CJC-1295, Ipamorelin), supplements, or other compounds. Each compound maintains its own independent schedule, escalation timeline, and logging history. The app also tracks potential interactions and gives you a holistic view of your entire compound stack.

Lifewheel supports the standard FDA-approved tirzepatide escalation schedule: 2.5 mg for weeks 1 through 4, 5 mg for weeks 5 through 8, 7.5 mg for weeks 9 through 12, 10 mg for weeks 13 through 16, 12.5 mg for weeks 17 through 20, and 15 mg from week 21 onward as the maintenance dose. You can also customize the duration at each dose level if your healthcare provider recommends a slower or modified escalation. The app tracks your exact position in the schedule and displays your progress visually.

Lifewheel is a protocol tracking and health logging tool. It does not prescribe, diagnose, or provide medical advice. The app helps you maintain accurate records of your tirzepatide protocol, which you can share with your healthcare provider. All dosing decisions should be made in consultation with your prescribing physician. Lifewheel is designed to complement, not replace, professional medical guidance.